Disruptive technologyStock brokersStock research & analytics02 November 2025, 17:30October’s Gift for Wall Street📆 October turned out to be a true gift for Wall Street — a rare occasion when both tech and…Read more
NewsStock brokersStock research & analytics01 November 2025, 12:00Market: a fine line between euphoria and caution📅 After the October rally — all eyes now on Palantir, Robinhood, and AMD (data as of November…Read more
Disruptive technologyNewsStock brokersStock research & analytics31 October 2025, 14:00Apple sets the tone again🍏 Once again, Apple has proven it knows how to win — not just riding the hype wave, but…Read more
CryptocurrencyNewsStock brokersStock research & analytics30 October 2025, 14:41Did Bitcoin fail to handle the political show?💸 Wednesday turned out to be a tense day for the crypto ETF market: on October 29, U.S. spot…Read more
NewsStock brokersStock research & analytics29 October 2025, 20:30“No guarantees!” — Powell cools investor enthusiasm after the rate cut⚡️In this article, we’ll take a look at the fresh (October 29, 2025) speech by our favorite…Read more
NewsStock brokersStock research & analytics29 October 2025, 18:00Mercedes-Benz: Record Drop in Net Profit🚗 The net profit of the German automaker Mercedes-Benz Group AG for the first nine months of 2025…Read more
Disruptive technologyNewsStock brokers29 October 2025, 16:00AI Becomes the New Oil: Nvidia Leads in Market Capitalization🚀 History loves big moments — and here’s one for the record books: right now, before our…Read more
NewsStock brokersStock research & analytics29 October 2025, 10:00Qualcomm Challenges Nvidia in the Server AI Market📢 The American corporation Qualcomm, known as a leader in mobile processors with its Snapdragon…Read more
Disruptive technologyNewsStock brokers29 October 2025, 08:00A Billion for Nokia: A Legend Reborn or a Strategic Move?📞 This week, Finnish company Nokia unexpectedly found itself in the spotlight of global markets.Read more
NewsStock brokersStock research & analytics28 October 2025, 18:00BeOne Medicines stock is up: the new king of oncology takes the stage!💊 BeOne Medicines is rapidly transforming from a little-known company into one of the key players…Read more